SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?


To: Jonathan Schonsheck who wrote (3710)7/14/1998 12:25:00 AM
From: paul goldstein  Read Replies (1) | Respond to of 4342
 
JONATHAN, ROBIN,
as i see it.and i may be incorrect..
the royalties would become sales in terms of a company revenues.
their work to check batches and so forth would all be done at cost plus fixed overhead plus a profit built in. they are not going to be doing all this work without being compensated..
anyway, back to the stock price..
i assume as the new marketing group signs up customers prln will get steady repeat work as well as royalties.
so its possible the next prln news will be a signing of customers into the program..
or, like others suggested, a move on thie drugs or herbs..
i just want to see us at the dollar level in as soon a time frame as posible as that would be an indication of street acceptance of their progress.
of course i see resistence at 3/4 and 25/32 area.
need some heavy volume to make the break out